InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（23 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
23
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Leonard Frank X, Directeur du Développement. Insider active across 1 company, notably NovoCure Ltd. Cumulatively, 36 filings have been published. Breakdown: 0 buy · 23 sells. Total volume traded: €5.1m. Activity tracked since 6 July 2021. The latest transaction was disclosed on 3 March 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Leonard Frank X
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报36 总计
150,000 股0Ordinary SharesSEC:0001822879-26-000003:0
9,734 股@ US$13.66381.5% 占其流量Ordinary SharesSEC:0001822879-26-000002:0
966 股@ US$12.810.1% 占其流量Ordinary SharesSEC:0001822879-25-000006:0
833 股@ US$15.130.1% 占其流量Ordinary SharesSEC:0001562180-25-005188:0
179,426 股0Ordinary SharesSEC:0001562180-25-004553:0
21,717 股@ US$17.21964.3% 占其流量Ordinary SharesSEC:0001562180-25-004426:0
54,975 股@ US$18.1912.8% 占其流量Ordinary SharesSEC:0001562180-25-002159:0
2,527 股@ US$18.53630.6% 占其流量Ordinary SharesSEC:0001562180-25-001976:0
10,277 股@ US$19.92192.6% 占其流量Ordinary SharesSEC:0001562180-25-001915:0
10,277 股@ US$19.92192.6% 占其流量Ordinary SharesSEC:0001562180-25-001834:0
598 股@ US$15.93770.1% 占其流量Ordinary SharesSEC:0001562180-24-007516:0
1,736 股@ US$12.240.3% 占其流量Ordinary SharesSEC:0001562180-24-006039:0
1,679 股@ US$16.02690.3% 占其流量Ordinary SharesSEC:0001562180-24-002247:0
102,249 股@ US$16.3020.7% 占其流量Ordinary SharesSEC:0001562180-24-001988:0
4,403 股@ US$76.15944.3% 占其流量Ordinary SharesSEC:0001562180-23-002581:0
844 股@ US$75.27790.8% 占其流量Ordinary SharesSEC:0001562180-23-002489:0
3,799 股@ US$75.32353.6% 占其流量Ordinary SharesSEC:0001562180-23-002359:0
18,621 股0Ordinary SharesSEC:0001645113-23-000031:0
2,345 股@ US$119.00773.5% 占其流量Ordinary SharesSEC:0001645113-23-000009:0
6,830 股0Ordinary SharesSEC:0001645113-22-000093:0
6,754 股@ US$76.017.1% 占其流量Ordinary SharesSEC:0001645113-22-000086:0
6,754 股@ US$84.377.8% 占其流量Ordinary SharesSEC:0001645113-22-000085:0
6,754 股@ US$77.357.2% 占其流量Ordinary SharesSEC:0001645113-22-000084:0
6,754 股@ US$77.007.1% 占其流量Ordinary SharesSEC:0001645113-22-000083:0
5,517 股@ US$7.150.5% 占其流量Ordinary SharesSEC:0001645113-22-000082:0
36 条申报中的 25 条
About Leonard Frank X
Leonard Frank X is Chief Executive Officer. He has 36 filings in total, all included in the recent sample covered here, and the recorded activity concerns NovoCure Ltd, with a modal transaction nature of sale. Over the period from 2021-07-08 to 2026-03-05, sales total 5116039 EUR and purchases 0 EUR.
